Blaise D - Search Results

1

Survey of early disapearance of BCR/ABL fusion transcript after allogeneic or autologous stem cell transplantation for chronic myelogenous leukemia.

Vey N, Balatzentko G, Lafage M, Sainty D, Bouabdallah R, Chabannon C, Blaise D, Gastaut JA, Gabert J. Vey N, et al. Among authors: blaise d. Leuk Lymphoma. 2001 Sep-Oct;42(5):945-52. doi: 10.3109/10428190109097713. Leuk Lymphoma. 2001. PMID: 11697649 Clinical Trial.

2

Intensive immunotherapy with recombinant IL2 after autologous bone marrow transplantation is associated with a high incidence of bacterial infections.

Blaise D, Stoppa AM, Viens P, Sainty D, Fossat C, Miquel M, Olive D, Bouabdallah R, Gabert J, Baume D, et al. Blaise D, et al. Bone Marrow Transplant. 1992 Aug;10(2):193-4. Bone Marrow Transplant. 1992. PMID: 1525610 No abstract available.

3

Is allogeneic bone marrow transplantation the best treatment for young adult patients with acute myeloid leukemia in first complete remission. The BGMT Group.

Reiffers J, Stoppa AM, Rigal-Huguet F, Michallet M, Marit G, Blaise D, Attal M, Corront B, Cony-Makhoul P, Gastaut JA, et al. Reiffers J, et al. Among authors: blaise d. Leukemia. 1992;6 Suppl 2:124-6. Leukemia. 1992. PMID: 1578913 No abstract available.

4

Interleukin-2 induces chemotactic deficiency in patients with onco hematologic malignancies and autologous bone marrow transplantation.

Stoppa AM, Fossat C, Blaise D, Viens P, Brandely M, Pourreau CN, Sainty D, Novakovitch G, Miquel M, Juhan-Vague I, et al. Stoppa AM, et al. Among authors: blaise d. Eur Cytokine Netw. 1991 Aug-Sep;2(4):231-7. Eur Cytokine Netw. 1991. PMID: 1661618

5

Histological evolution of peripheral T-cell lymphomas. Study of six cases.

Horschowski N, Sainty D, Sebahoun G, George F, Bouabdallah R, Stoppa AM, Maraninchi D, Blaise D, Carcassonne Y. Horschowski N, et al. Among authors: blaise d. Pathol Biol (Paris). 1991 Sep;39(7):692-6. Pathol Biol (Paris). 1991. PMID: 1758721

6

Recombinant interleukin-2 (rIL-2) after autologous bone marrow transplantation (BMT): a pilot study in 19 patients.

Blaise D, Viens P, Olive D, Stoppa AM, Gabert J, Pourreau CN, Attal M, Gaspard MH, Mannoni P, Jasmin C, et al. Blaise D, et al. Eur Cytokine Netw. 1991 Mar-Apr;2(2):121-9. Eur Cytokine Netw. 1991. PMID: 1813015 Clinical Trial.

7

High-dose recombinant interleukin-2 and acute myeloid leukemias in relapse.

Maraninchi D, Blaise D, Viens P, Brandely M, Olive D, Lopez M, Sainty D, Marit G, Stoppa AM, Reiffers J, et al. Maraninchi D, et al. Among authors: blaise d. Blood. 1991 Nov 1;78(9):2182-7. Blood. 1991. PMID: 1932739 Free article.

8

Prevention of acute GVHD by in vivo use of anti-interleukin-2 receptor monoclonal antibody (33B3.1): a feasibility trial in 15 patients.

Blaise D, Olive D, Hirn M, Viens P, Lafage M, Attal M, Stoppa AM, Gabert J, Gastaut JA, Camerlo J, et al. Blaise D, et al. Bone Marrow Transplant. 1991 Aug;8(2):105-11. Bone Marrow Transplant. 1991. PMID: 1933050 Clinical Trial.

9

Influence of mixed chimerism on the results of allogeneic bone marrow transplantation for leukemia.

Bertheas MF, Lafage M, Levy P, Blaise D, Stoppa AM, Viens P, Mannoni P, Maraninchi D. Bertheas MF, et al. Among authors: blaise d. Blood. 1991 Dec 1;78(11):3103-6. Blood. 1991. PMID: 1954396 Free article.

10

Mixed chimerism after allogeneic bone marrow transplantation for leukemias.

Bertheas MF, Lafage M, Blaise D, Stoppa AM, Viens P, Mannoni P, Maraninchi D. Bertheas MF, et al. Among authors: blaise d. Bone Marrow Transplant. 1990 Jul;6 Suppl 1:61-3. Bone Marrow Transplant. 1990. PMID: 2390641 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

767 results

Search Page

Filters